GlassScriptPhysician profile
Phillip Kravetz
NPI 1881660264
$223,913.38
in general payments reported to CMS, 2019-2025
22 companies · $68K in 2025
The $68K reported for 2025 was more than what 90% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $19K · 2021: $11K · 2022: $12K · 2023: $25K · 2024: $59K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $149K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,438 · Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $149,416.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,437.91 |
| Food and Beverage | $1,136.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $122,843.80 | 2019-2025 | |
| Osseus Fusion Systems, LLC | $63,214.56 | 2023-2024 | |
| Orthofix Medical, INC. | $21,330.86 | 2019-2025 | Forza, Physio-Stim, Spinal-Stim |
| Kyocera Medical Technologies, INC. | $9,037.90 | 2020-2025 | |
| Curiteva, INC. | $2,547.23 | 2021-2023 | |
| Geistlich Pharma, North America, INC. | $1,514.10 | 2019 | |
| Stryker Corporation | $1,056.13 | 2019-2024 | N/A |
| Abbott Laboratories | $675.28 | 2019 | |
| Spinal Elements, INC. | $422.29 | 2019-2022 | |
| Nexxt Spine LLC | $228.56 | 2023-2024 | Nexxt Spine Product Portfolio, Matrixx Lateral System, Nexxt Spine Product Offerings |
| Nuvasive, INC. | $217.11 | 2019-2020 | |
| Globus Medical, INC. | $186.88 | 2021-2024 | Hedron Ia, Hedron Ic, Excelsius3d Imaging System |
| Life Spine, INC. | $139.25 | 2021 | |
| Depuy Synthes Sales INC. | $137.95 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $94.14 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carlsmed, INC. | $71.87 | 2021-2022 | |
| Medtronic USA, INC. | $62.80 | 2019 | |
| Stimwave Technologies Incorporated | $46.55 | 2019 | |
| Cerapedics INC. | $30.03 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $21.70 | 2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $20.77 | 2023 | Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Kravetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.